Ameet Nath­wani re­bounds from Sanofi purge to helm Dew­point; Ali Mor­taza­vi named CEO at e-ther­a­peu­tics

→ Sanofi vet Ameet Nath­wani has joined Arie Bellde­grun and ARCH Ven­ture Part­ners-backed Dew­point Ther­a­peu­tics as its new CEO. Dur­ing his tenure at Sanofi, Nath­wani served as CMO, chief dig­i­tal of­fi­cer and ex­ec­u­tive com­mit­tee mem­ber. Pri­or to that, Nath­wani com­plet­ed a 12-year stint at No­var­tis, where he held roles such as glob­al head of the crit­i­cal care busi­ness fran­chise and SVP and glob­al de­vel­op­ment head of the car­dio­vas­cu­lar and me­tab­o­lism fran­chise.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN